Senescence in premalignant tumours
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Oncogene-induced senescence is a cellular response that may be crucial for protection against cancer development, but its investigation has so far been restricted to cultured cells that have been manipulated to overexpress an oncogene. Here we analyse tumours initiated by an endogenous oncogene, ras, and show that senescent cells exist in premalignant tumours but not in malignant ones. Senescence is therefore a defining feature of premalignant tumours that could prove valuable in the diagnosis and prognosis of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lastly, in mice and humans, a senescence response to strong mitogenic signals, such as those delivered by certain oncogenes, prevents premalignant lesions from progressing to malignant cancers [ 16 – 19 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [16]
In the citing paper
“In addition to identifying known cell-cycle regulators, these studies identified DCR2 as a common marker of senescence (Collado et al., 2005), later shown to characterize other types of senescence.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Collado et al., 2005
In the citing paper
“OIS or senescence induced by loss of a tumor suppressor was verified in vivo in human and murine preneoplastic lesions (Collado et al., 2005; Gorgoulis and Halazonetis, 2010; Kuilman and Peeper, 2009) and primary or treated neoplasias (Haugstetter et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Collado et al., 2005
In the citing paper
“Studies in various mouse models, supported by correlative evidence from human- derived tissue samples, have underscored the tumour- suppressive role of OIS 81,120-123 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [122]
In the citing paper
“This type of oncogene-induced senescence (OIS) is frequently observed in premalignant and benign tumour tissues [37 -39] but not in advanced malignant tumours, where cancer cells have already bypassed senescence.”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [38]
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Self-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
Tuveson, D. A., Shaw, A. T., Willis, N. A., Silver, D. P., Jackson, E. L., Chang, S., Mercer, K. L., Grochow, R., Hock, H., Crowley, D., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00085-6 · Cited by 798
p19ARF links the tumour suppressor p53 to Ras
Palmero, I., Pantoja, C., & Serrano, M. (1998) · Nature · doi:10.1038/25870 · Cited by 615
Self-citationTumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
Guerra, C., Mijimolle, N., Dhawahir, A., Dubus, P., Barradas, M., Serrano, M., Campuzano, V., & Barbacid, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00191-0 · Cited by 571
Self-citation
Cited by
Items 901–1,000 of 1,005
Obesity-induced neuronal senescence: Unraveling the pathophysiological links
Ghosh, P., Fontanella, R. A., Scisciola, L., Taktaz, F., Pesapane, A., Basilicata, M. G., Tortorella, G., Matacchione, G., Capuano, A., Vietri, M. T., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102533 · Cited by 25
Stem cell MicroRNAs in senescence and immortalization: novel players in cancer therapy
Leal, J. A., Feliciano, A., & LLeonart, M. E. (2011) · Medicinal Research Reviews · doi:10.1002/med.20246 · Cited by 22
Adrados, I., Larrasa-Alonso, J., Galarreta, A., López‐Antona, I., Menéndez, C., Abad, M., Gil, J., Moreno‐Bueno, G., & Palmero, I. (2015) · Oncogene · doi:10.1038/onc.2015.408 · Cited by 25
Self-citationCotarelo, C., Schad, A., Kirkpatrick, C. J., Sleeman, J. P., Springer, E., Schmidt, M., & Thaler, S. (2016) · Oncotarget · doi:10.18632/oncotarget.12432 · Cited by 23
Zhang, S., Zeng, N., Alowayed, N., Singh, Y., Cheng, A., Lang, F. J. W., & Salker, M. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183681 · Cited by 25
Keratin 17 Suppresses Cell Proliferation and Epithelial-Mesenchymal Transition in Pancreatic Cancer
Zeng, Y., Zou, M., Liu, Y., Que, K., Wang, Y., Liu, C., Gong, J., & You, Y. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.572494 · Cited by 25
Molecular Basis for the Cellular Senescence Program and Its Application to Anticancer Therapy
Katakura, Y. (2006) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.70.1076 · Cited by 23
Stem cells, cancer, and epigenetics
Baylin (2009) · StemBook · doi:10.3824/stembook.1.50.1 · Cited by 26
“However, simple introduction of such mutations into mature cells often triggers apoptosis or senescence (Collado et al., 2007; Collado et al., 2005; Lowe et al., 2004) suggesting that other cell changes may be essential for the mutations to play their tumorigenic role.”
BackgroundNakanome, A., Brydun, A., Matsumoto, M., Ota, K., Funayama, R., Nakayama, K., Ono, M., Shiga, K., Kobayashi, T., & Igarashi, K. (2012) · Oncogene · doi:10.1038/onc.2012.336 · Cited by 23
Senescence in amniocytes and placentas from trisomy 21 pregnancies
Amiel, A., Fejgin, M. D., Liberman, M., Sharon, Y., Kidron, D., & Biron‐Shental, T. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.768982 · Cited by 24
“In vivo, cell proliferation is retained by the senescence mechanism, which harbors activated oncogenes and is important for tumor suppression mechanisms [5,6].”
BackgroundTumor Suppression for ARFicionados: The Relative Contributions of p16INK4a and p14ARF in Melanoma
Peters, G. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn156 · Cited by 25
Medendorp, K., van Groningen, J. J. M., Vreede, L., Hetterschijt, L., Brugmans, L., van den Hurk, H., & van Kessel, A. G. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.04.022 · Cited by 22
Park, A.-M., Tsunoda, I., & Yoshie, O. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003310 · Cited by 23
“By data mining of NCBI’s Gene Expression Omnibus microarray database, we indeed found decrease of HSP27 mRNA in some senescence cells: liver stellate cells (48) and premalignant lung cells (49).”
MethodMuniz, L., Lazorthes, S., Delmas, M., Ouvrard, J., Aguirrebengoa, M., Trouche, D., & Nicolas, E. (2020) · RNA Biology · doi:10.1080/15476286.2020.1812910 · Cited by 23
“IMR90 hTERT MEK1-ER cells [54] were a”
MethodSaleh, T., Khasawneh, A. I., Himsawi, N. M., Abu-Raideh, J. A., Ejeilat, V., Elshazly, A. M., & Gewirtz, D. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415512 · Cited by 24
“In support of senescence as a tumor suppressive mechanism, senescent cells have been shown to accumulate in premalignant lesions [9].”
BackgroundChang, T., & Hung, W. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.23293 · Cited by 21
Khatami, M. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0003-z · Cited by 23
Ras Effector Mutant Expression Suggest a Negative Regulator Inhibits Lung Tumor Formation
Vandal, G., Geiling, B., & Dankort, D. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084745 · Cited by 24
“: oncogene-induced senescence) [36], adenocarcinomas appear as early as 16 weeks post-induction.”
BackgroundThe Importance of Senescence in Ionizing Radiation-Induced Tumour Suppression
Vávrová, J., & Řezáčová, M. (2011) · Folia Biologica · doi:10.14712/fb2011057020041 · Cited by 24
“Another cyclin-dependent kinase inhibitor – p15INK4b – was identified as marker of Ras-induced senescence (Collado et al., 2005).”
BackgroundLi, Z., Ding, S., Zhong, Q., Li, G., Zhang, Y., & Huang, X. (2015) · PubMed · Cited by 21
Crowder, R. N., Dicker, D. T., & El‐Deiry, W. S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.713545 · Cited by 23
“Some tumor cells express elevated decoy receptors (25), and decoy receptor expression has also been associated with cellular senescence (26).”
BackgroundMelzer, C., von der Ohe, J., Hass, R., & Ungefroren, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071574 · Cited by 23
“In fact, senescence-like phenotypes have been reported in early stages of breast tumors [6,7].”
BackgroundIngenhag, D., Reister, S., Auer, F., Bhatia, S., Wildenhain, S., Picard, D. J., Remke, M., Hoell, J. I., Kloetgen, A., Sohn, D., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.189407 · Cited by 22
Fanconi anemia proteins counteract the implementation of the oncogene-induced senescence program
Helbling-Leclerc, A., Dessarps-Freichey, F., Evrard, C., & Rosselli, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-53502-w · Cited by 22
Nelson, N. D., Litzky, L. A., Peranteau, W. H., & Pogoriler, J. E. (2020) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001488 · Cited by 23
The role of autophagy in escaping therapy-induced polyploidy/senescence
Dudkowska, M., Staniak, K., Bojko, A., & Sikora, E. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.004 · Cited by 22
Alhaddad, L., Osipov, A. N., & Leonov, S. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113577 · Cited by 22
Targeting KRAS in pancreatic cancer: Emerging therapeutic strategies
Khan, S. U., Budamagunta, V., & Zhou, D. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2023.02.004 · Cited by 23
Walen, K. H. (2007) · Cell Biology International · doi:10.1016/j.cellbi.2007.06.015 · Cited by 27
“These ideas are partially supported by recent findings in early, pre-cancerous lesions, which include: presence of senescent cells, eroded telomeres, CIN and polyploidy (Barrett et al., 2003; Collado et al., 2005).”
BackgroundParikh, N., Shuck, R. L., Nguyen, T., Herron, A. J., & Donehower, L. A. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0089 · Cited by 22
“Some oncogenic K-Ras mouse models revealed induction of tumor suppressors such as p16 and p19 in earlystage lesions (19, 20), presumably as a key defense mechanism that blocks further progression of the premalignant tumors to malignant tumors.”
BackgroundQuantitative Analysis of Cellular Senescence in Culture and In Vivo
Zhao, J., Fuhrmann‐Stroissnigg, H., Gurkar, A. U., Flores, R. R., Dorronsoro, A., Stolz, D. B., Croix, C. M. S., Niedernhofer, L. J., & Robbins, P. D. (2017) · Current Protocols in Cytometry · doi:10.1002/cpcy.16 · Cited by 23
Cellular senescence induces replication stress with almost no affect on DNA replication timing
Rivera‐Mulia, J. C., Schwerer, H., Besnard, E., Desprat, R., Trevilla‐García, C., Sima, J., Bensadoun, P., Zouaoui, A., Gilbert, D. M., & Lemaître, J.-M. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1491235 · Cited by 20
“CREB5 was previously identified as upregulated in a model of senescence bypass [46,70].”
BackgroundSarcoid-derived fibroblasts: Links between genomic instability, energy metabolism and senescence
Potocki, L., Lewińska, A., Klukowska‐Rötzler, J., Bielak-Żmijewska, A., Grabowska, W., Rzeszutek, I., Kaminska, P., Roga, E., Bugno‐Poniewierska, M., Słota, E., et al. (2013) · Biochimie · doi:10.1016/j.biochi.2013.10.010 · Cited by 23
Lu, Y., Li, L., Chen, H., Jing, X., Wang, M., Ge, L., Yang, J., Zhang, M., & Tang, X. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s284182 · Cited by 21
Iron Metabolism in Cancer and Senescence: A Cellular Perspective
Crescenzi, E., Leonardi, A., & Pacifico, F. (2023) · Biology · doi:10.3390/biology12070989 · Cited by 20
“Pre-malignant and malignant cancer cells can also undergo senescence and accumulate in pre-neoplastic lesions and in neoplastic tissue from patients with cancer [33].”
BackgroundToo big not to fail: emerging evidence for size‐induced senescence
Manohar, S., & Neurohr, G. E. (2023) · FEBS Journal · doi:10.1111/febs.16983 · Cited by 22
Abramovitz, M., Barwick, B. G., Willis, S., Young, B. M., Catzavelos, C., Li, Z., Kodani, M., Tang, W., Bouzyk, M., Moreno, C. S., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.355 · Cited by 20
“These data show that the concordance of DASL data with IHC data for all three receptors is very high, which is consistent with previous studies relating mRNA and IHC protein levels (Cronin et al, 2004; Gong et al, 2007).”
MethodResultAccelerated cellular senescence in myelodysplastic syndrome
Wang, Y.-Y., Cen, J., He, J., Shen, H.-J., Liu, D., Li, Y., Qi, X., & Chen, Z. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.09.002 · Cited by 20
“Therefore, p16INK4a, the previous known tumor suppressor gene, has also been identified as senescence markers [7].”
BackgroundThe role of the NORE1A tumor suppressor in Oncogene-Induced Senescence
Barnoud, T., Schmidt, M., Donninger, H., & Clark, G. J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.030 · Cited by 27
“The detection of Ras-mediated senescence in cell culture systems, primary human tumors, and animal models confirms OIS as a physiologically relevant tumor suppression process (16,20-24).”
Chronic Infections: A Possible Scenario for Autophagy and Senescence Cross-Talk
Aguilera, M. O., Delgui, L. R., Romano, P. S., & Colombo, M. I. (2018) · Cells · doi:10.3390/cells7100162 · Cited by 21
Shilkaitis, A. L., Green, A., & Christov, K. T. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3013 · Cited by 22
“Studies by Collado et al (50) on a mouse model of lung carcinogenesis that expresses k-ras12 v12 oncogene showed SC in benign lesions (adenomas), but not in carcinomas, thus supporting our in vivo data on mammary carcinogenesis.”
ResultVitis, S. D., Treglia, A. S., Ulianich, L., Turco, S., Terrazzano, G., Lombardi, A., Miele, C., Garbi, C., Bèguinot, F., & Jeso, B. D. (2011) · Neoplasia · doi:10.1593/neo.101152 · Cited by 20
“Thismechanism is operational in vivo, as demonstrated for murine lung adenomas, T-cell lymphomas, and benign melanocytic nevi [20–22].”
BackgroundDiMauro, T., Cantor, D. J., Bainor, A. J., & David, G. (2014) · Oncogene · doi:10.1038/onc.2014.322 · Cited by 20
“Several studies have shown that the expression of senescence markers is associated with low proliferation in a wide variety of cancer preneoplastic lesions including lung adenoma, melanocytic naevi and PanIN (3-5).”
BackgroundMRGing Chromatin Dynamics and Cellular Senescence
Garcia, S. N., & Pereira‐Smith, O. M. (2008) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-008-9006-7 · Cited by 23
Cytokine-induced senescence for cancer surveillance
Wieder, T., Brenner, E., Braumüller, H., Bischof, O., & Röcken, M. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9667-z · Cited by 20
“This interpretation of the state of silent tumors has now been complemented by four non-toxic mechanisms, namely (i) active cell cycle control through regulation of cyclin-dependent kinases [57]; (ii) induction of cellular senescence [9, 14, 15, 58]; (iii) control of differentiation by regulating inhibitor of DNA bind…”
BackgroundKsiążek, K., Piątek, K., & Witowski, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.026 · Cited by 22
“Detection of senescent cells in vivo is difficult and documented only occasionally in skin [21], melanocytic nevi [22], atherosclerotic plaques [23], hyperplastic prostate [24], and pulmonary adenomas [25].”
BackgroundToillon, R., Magné, N., Laïos, I., Castadot, P., Kinnaert, E., Houtte, P. V., Desmedt, C., Leclercq, G., & Lacroix, M. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.11.040 · Cited by 21
Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise
Hinterleitner, C., Goldberg, H. V., McHugh, D., Barthet, V. J. A., Filliol, A. A., & Lowe, S. W. (2026) · Cell · doi:10.1016/j.cell.2026.03.005 · Cited by 24
Thompson, E. L., Hu, J., & Niedernhofer, L. J. (2021) · Cancers · doi:10.3390/cancers13092241 · Cited by 20
Senolysis Reduces Senescence in Veins and Cancer Cell Migration
Estepa‐Fernández, A., Alfonso, M., Morellá‐Aucejo, Á., García‐Fernández, A., Lérida‐Viso, A., Lozano‐Torres, B., Galiana, I., Soriano‐Teruel, P. M., Sancenón, F., Orzáez, M., et al. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100149 · Cited by 20
Hrncir, H. R., Hantelys, F., & Gracz, A. D. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.02.012 · Cited by 21
The cerebral cavernous malformation 3 gene is necessary for senescence induction
Guerrero, A., Iglesias, C., Raguz, S., Floridia, E., Gil, J., Pombo, C. M., & Zalvide, J. B. (2015) · Aging Cell · doi:10.1111/acel.12316 · Cited by 19
“It was first described in cells in culture and is now widely accepted as an important antioncogenic mechanism in vivo (Braig et al., 2005; Collado et al., 2005; Michaloglou et al., 2005).”
BackgroundSelf-citationChen, J., Chen, K.-H., Fu, B.-Q., Zhang, W., Dai, H., Lin, L.-R., Wang, L., & He, Y. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.04.008 · Cited by 21
“DcR2 is highly expressed in senescent cells and has been used as amarker for aging tumor cells (Collado et al. 2005).”
BackgroundMethodApproach to the Subsolid Nodule
Mase, V. J., & Detterbeck, F. C. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.11.004 · Cited by 19
Hernández‐Mercado, E., Prieto‐Chávez, J. L., Arriaga‐Pizano, L., Hernández-Gutiérrez, S., Mendlovic, F., Königsberg, M., & López‐Díazguerrero, N. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910215 · Cited by 19
Kellers, F., Fernandez, A., Konukiewitz, B., Schindeldecker, M., Tagscherer, K. E., Heintz, A., Jesinghaus, M., Roth, W., & Foersch, S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.865230 · Cited by 23
Recent Advances in Strategies for Imaging Detection and Intervention of Cellular Senescence
Li, J., Bi, Z., Wang, L., Xia, Y., Xie, Y., & Liu, Y. (2022) · ChemBioChem · doi:10.1002/cbic.202200364 · Cited by 19
Epigenetic mechanisms in senescence, immortalisation and cancer
Carnero, A., & LLeonart, M. E. (2010) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2010.00154.x · Cited by 20
“The detection of senescent cells in benign tumours and their possible association with the initial stages of tumourigenesis have placed senescence at the top of the cancer research agenda (Collado et al., 2005; Chen et al., 2005).”
BackgroundOncogene-triggered suppression of DNA repair leads to DNA instability in cancer
Yaglom, J. A., McFarland, C. D., Mirny, L. A., & Sherman, M. Y. (2014) · Oncotarget · doi:10.18632/oncotarget.2259 · Cited by 20
“OIS represents an early barrier to neoplastic transformation [11-20], and therefore in order to become cancerous, cells acquire mutations or epigenetic changes that allow them to “turn off” the senescence program.”
BackgroundPituitary Tumour-Transforming Gene (PTTG) and Pituitary Senescence
Chesnokova, V., & Melmed, S. K. (2009) · Hormone Research in Paediatrics · doi:10.1159/000192443 · Cited by 19
Götz, R. (2008) · Cancer Cell International · doi:10.1186/1475-2867-8-7 · Cited by 20
“Since a substantial number of cells in premalignant tumours underwent oncogeneinduced senescence, it has been proposed that this mechanism might limit tumour initiation and/or tumour progression from premalignant adenomas to malignant adenocarcinomas [36].”
Zhou, L., DeMarco, K. D., Murphy, K. C., Wu, Z., Li, J., Johnson, C., Liu, B., Giwa, H. K., Ma, B., Bhalerao, N., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-1212 · Cited by 22
Papaspyropoulos, A., Hazapis, O. G., Altulea, A., Polyzou, A., Verginis, P., Evangelou, K., Fousteri, M. I., Papantonis, A., Demaria, M., & Gorgoulis, V. G. (2023) · Aging Cell · doi:10.1111/acel.13893 · Cited by 18
Senescence program and its reprogramming in pancreatic premalignancy
Yang, K., Li, X., & Xie, K. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06040-3 · Cited by 21
Sun, Z., Pan, X., Zou, Z., Ding, Q., Wu, G., & Peng, G. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0445-1 · Cited by 18
“Senescence growth arrest usually depends on the activation of the CDK inhibitors (p21CIP1 and p16INK4A) [30, 31], components of the tumor-”
BackgroundThe roles of homologous recombination and the immune system in the genomic evolution of cancer
Nandi, B., Talluri, S., Kumar, S., Yenumula, C., Gold, J. S., PRABHALA, R. H., Munshi, N. C., & Shammas, M. A. (2018) · Journal of Translational Science · doi:10.15761/jts.1000282 · Cited by 19
“Cellular senescence is considered to be a tumor-suppressive mechanism that prevents malignant transformation [79,80].”
BackgroundGenes and pathways involved in senescence bypass identified by functional genetic screens
Roupakia, E., Markopoulos, G. S., & Kolettas, E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111432 · Cited by 20
Trayssac, M., Clarke, C. J., Stith, J. L., Snider, J. M., Newen, N., Gault, C. R., Hannun, Y. A., & Obeid, L. M. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03281-4 · Cited by 21
MOB3A Bypasses BRAF and RAS Oncogene-Induced Senescence by Engaging the Hippo Pathway
Dutchak, K., Garnett, S., Nicoll, M., de Bruyns, A., & Dankort, D. L. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0767 · Cited by 19
Preventing clonal evolutionary processes in cancer: Insights from mathematical models
Rodriguez-Brenes, I. A., & Wodarz, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501730112 · Cited by 22
“Senescence response in vivo after oncogenic activation has been observed in mice, where tumors initiated by the endogenous expression of the oncogene ras showed an abundance of senescent cells in premalignant lesions in the lung but no signs of cellular senescence in lung adenocarcinomas (23).”
BackgroundPrigge, E., Urban, K., Stiegler, S., Müller, M., Kloor, M., Mai, S., Ottstadt, M., Lohr, F., Wenz, F. K., Wagner, S., et al. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.08.001 · Cited by 19
“Considering the observation of KRAS mutation–induced p16INK4a overexpression in the context of oncogene-induced senescence or epithelial-mesenchymal transition in tumorous tissue [10,23],KRASmutations might be particularly expected in anogenital and head and neck SCC with HPV-independent p16INK4a overexpression.”
BackgroundA population of BJ fibroblasts escaped from Ras-induced senescence susceptible to transformation
Kohsaka, S., Sasai, K., Takahashi, K., Akagi, T., Tanino, M. A., Kimura, T., Nishihara, H., & Tanaka, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.082 · Cited by 18
“Discussion OIS provides an initial barrier to tumorigenesis in vivo, as preneoplastic lesions contain a lot of cells indicating senescence markers [12; 13; 14].”
BackgroundVredeveld, L. C. W., Rowland, B. D., Douma, S., Bernards, R., & Peeper, D. S. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp296 · Cited by 18
Yoshizuka, N., Lai, M., Liao, R., Cook, R., Xiao, C., Han, J., & Sun, P. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0576 · Cited by 18
“Nevertheless, oncogenic ras induced accumulation of other senescence markers, including DcR2, p16, and p19 (12, 13, 22), and the induction of these senescence markers by ras was either abolished or greatly reduced in PRAK / splenocytes (Fig.”
BackgroundAssessment and consequences of cell senescence in atherosclerosis
Garrido, A. M., & Bennett, M. R. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000327 · Cited by 19
“Several studies have demonstrated that SAHF formation is related to senescence in vivo with an increase in premalignant tumours [55] and aging [56,57]; however, the role of”
BackgroundThe Dual Role of Senescence in Pancreatic Ductal Adenocarcinoma
Porciuncula, A., Hajdu, C. H., & David, G. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.05.006 · Cited by 20
Reduced Basal Nitric Oxide Production Induces Precancerous Mammary Lesions via ERBB2 and TGFβ
Ren, G., Zheng, X., Bommarito, M., Metzger, S., Walia, Y., Letson, J., Schroering, A. G., Nestor‐Kalinoski, A. L., Weaver, D. A., Figy, C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43239-x · Cited by 19
Callejas‐Valera, J. L., Guinea‐Viniegra, J., Ramírez‐Castillejo, C., Recio, J. A., Galán‐Moya, E. M., Martinez, N. J., Rojas, J. M., y Cajal, S. R., & Sánchez‐Prieto, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709230200 · Cited by 20
The Yin-Yang of DNA Damage Response: Roles in Tumorigenesis and Cellular Senescence
Li, X., Xu, H., Chong-an, X., Lin, M., Song, X., Yi, F., Feng, Y., Coughlan, K. A., Cho, W., Kim, S. W., et al. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14022431 · Cited by 20
“Senescent cells and their specific markers, such as SA-β-Gal, were also present in precancerous lesions [53,59–64].”
BackgroundMammary stem and progenitor cells: Tumour precursors?
Paguirigan, A. L., Beebe, D. J., Liu, B., & Alexander, C. M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.048 · Cited by 18
“Adenomas induced by this route would be expected to comprise senescent cells and to express markers characteristic of ageing tissues.(70,71) If the mutation occurs in a stem cell this would create a truly potent tumour precursor cell.”
BackgroundPotential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions
Saleh, T., & Carpenter, V. J. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000361 · Cited by 17
“…(Rane et al., 2002; Beausejour et al., 2003; Sarkisian et al., 2007; Carri (cid:1) ere et al., 2011), which explains, in part, the accumulation of OIS cells in premalignant lesions of both spontaneous and ectopic (vector-driven oncogene expression) experimental models (Collado et al., 2005).”
The microbiota and aging microenvironment in pancreatic cancer: Cell origin and fate
Chen, Z., Wang, Z., Du, Y., Shi, H., & Zhou, W. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188826 · Cited by 17
Wuestefeld, A., Iakovleva, V., Yap, S. X. L., Ong, A. B. L., Huang, D. Q., Shuen, T. W. H., Toh, H. C., Dan, Y. Y., Zender, L., & Wüestefeld, T. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1477 · Cited by 18
Aging and oral squamous cell carcinoma development: the role of cellular senescence
Niklander, S. E., Aránguiz, P., Faunes, F., & Flores, R. (2023) · Frontiers in Oral Health · doi:10.3389/froh.2023.1285276 · Cited by 20
Chiba, M., Miyata, K., Okawa, H., Tanaka, Y., Ueda, K., Seimiya, H., & Takahashi, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216399 · Cited by 17
Majer, A. D., Hua, X., & Katona, B. W. (2024) · Genes · doi:10.3390/genes15091231 · Cited by 20
“Activation of the Kras-mediated oncogene-induced senescence program is a key barrier to the initiation of lung cancer [371].”
BackgroundReddy, H. K. D. L., Graña, X., Dhanasekaran, D. N., Litvin, J., & Reddy, E. P. (2010) · Genes & Cancer · doi:10.1177/1947601909358105 · Cited by 27
Chromatin: a molecular interface between cancer and aging
Cruickshanks, H. A., & Adams, P. D. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.007 · Cited by 17
Cancer as a disease of tissue pattern formation
Marongiu, F., Doratiotto, S., Sini, M., Serra, M. P., & Laconi, E. (2012) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2012.08.001 · Cited by 23
Raouf, S., Weston, C. R., Yucel, N. D., & Reproducibility Project: Cancer Biology (2015) · eLife · doi:10.7554/elife.04105 · Cited by 17
“DOI: 10.7554/eLife.04105 1 of 14”
InfluentialXiao, Y., Zou, P., Wang, J., Song, H. K., Zou, J., & Liu, L. (2012) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-012-0057-z · Cited by 19
Michaloglou, C., Soengas, M. S., Mooi, W. J., & Peeper, D. S. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701221 · Cited by 24
“…in vivo lesions, including human dermal neurofibromas (Courtois-Cox et al., 2006), human and murine prostatic adenomas (Chen et al., 2005), murine lung adenomas, pancreatic intraductal neoplasias (Collado et al., 2005), murine lymphomas (Braig et al., 2005), and murine melanomas (Ha et al., 2007).”
BackgroundSenescence in intraductal papillary mucinous neoplasm of the pancreas
Miyasaka, Y., Nagai, E., Ohuchida, K., Fujita, H., Nakata, K., Hayashi, A., Mizumoto, K., Tsuneyoshi, M., & Tanaka, M. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.03.007 · Cited by 16
Vickridge, E., Faraco, C. C. F., Lo, F., Rahimian, H., Liu, Z. Y., Samavarchi‐Tehrani, P., Djerir, B., Ramdzan, Z. M., Leduy, L., Maréchal, A., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1037 · Cited by 17
MacroH2A suppresses the proliferation of the B16 melanoma cell line
Lei, S., Long, J., & LI, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2482 · Cited by 18
“Similar results have previously been reported in other forms of human cancer, including testicular, ovarian, lung, bladder, cervical, breast, colon and endometrial cancer (25-30).”
McGowan, E. M., Tran, N., Alling, N., Yagoub, D., Sedger, L. M., & Martiniello‐Wilks, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042246 · Cited by 18
“Cells with all the hallmarks of senescence are frequently observed in pre-malignant lesions, but are rare in malignant tumours, suggesting senescence is an early cellular mechanism that prevents carcinogenesis [56].”
BackgroundAdisetiyo, H., Liang, M., Liao, C., Aycock-Williams, A., Cohen, M. B., Xu, S., Neamati, N., Conway, E. M., Cheng, C. Y., Nikitin, A. Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069484 · Cited by 19
“This finding is consistent with previous reports that senescence may be an initial barrier in cancer development [37–39], and that senescent cells exist in premalignant tumors but not in malignant ones [39].”
Resultα-Catulin knockdown induces senescence in cancer cells
Fan, L.-C., Chiang, W., Liang, C.-H., Tsai, Y.-T., Wong, T.-Y., Chen, K. C., Hong, T.-M., & Chen, Y.-L. (2011) · Oncogene · doi:10.1038/onc.2010.637 · Cited by 17
“Notably, endogenous SA-b-gal activity and the oncogene-induced senescence marker DcR2 (Collado et al., 2005) were higher in a-catulinsilenced cancer cells 6 days after infection with a-catulin shRNA viruses (Figure 1g; Supplementary Figure 1).”
BackgroundFeunteun, J., Ostyn, P., & Delaloge, S. (2022) · iScience · doi:10.1016/j.isci.2022.104217 · Cited by 20
“Collado et al. reported the first demonstration of such an effect induced by oncogene-induced senescence (OIS) in KrasV12 knockin mice that develop lung adenoma which rarely progress into tumors.”
BackgroundHan, Y., Micklem, G., & Kim, S. Y. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101849 · Cited by 19
“…Raf and MEK remain the most well-studied and well-established in vitro (Lin et al., 1998; Michaloglou et al., 2005; Narita et al., 2003; Wei et al., 1999) and in vivo (Braig et al., 2005; Collado et al., 2005; Dankort et al., 2007; Dhomen et al., 2009; Sarkisian et al., 2007) models of OIS.”
Background
Metadata
- Authors
- Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., Beach, D., & Serrano, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Imperial College London (GB)
- Consejo Superior de Investigaciones Científicas (ES)
- Universidad Complutense de Madrid (ES)
- Corresponding author
- Serrano, Manuel
- ORCID
- Venue
- Nature
- Published
- 2005-08-04
- Volume
- 436
- Issue
- 7051
- Pages
- 642-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2067117191
- Cited by
- 1,482
- References
- 7
- Citations by year
- 2026: 31 · 2025: 40 · 2024: 59 · 2023: 58 · 2022: 57 · 2021: 74 · 2020: 87 · 2019: 55 · 2018: 53 · 2017: 68 · 2016: 67 · 2015: 73 · 2014: 76 · 2013: 81 · 2012: 81
- FWCI
- 46.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, oncogene-induced senescence, oncogenic Ras, lymphoma, SUV39H1, histone methyltransferase, epigenetic regulation, melanoma, p53, PTEN mutation, prostate cancer, tumor suppression, cancer diagnosis and prognosis
- MeSH terms
- Adenocarcinoma, Alleles, Animals, beta-Galactosidase, Cell Transformation, Neoplastic, Disease Models, Animal, Heterochromatin, Lung Neoplasms, Mice, Transgenic, Precancerous Conditions, Genes, ras, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Cellular Senescence, Disease Progression, Cyclin-Dependent Kinase Inhibitor p16, Oligonucleotide Array Sequence Analysis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.